SAM
HALO icon

SEB Asset Management’s Halozyme HALO Stock Holding History

SEB Asset Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.86M Buy
74,918
+40,218
+116% +$2.74M 0.02% 435
2026
Q1 		$2.24M Buy
+34,700
New +$2.45M 0.01% 572

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

SEB Asset Management's HALO Position: Q2 2026 in Review

SEB Asset Management increased its Halozyme (HALO) stake by 116% in Q2 2026, buying an estimated $2.74M and bringing the position to 74,918 shares worth $5.86M. The position accounts for 0.02% of the portfolio, ranked #435.

SEB Asset Management first reported a position in HALO in Q1 2026 and has held it in 2 quarters since. 629 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • SEB Asset Management held 74,918 shares of Halozyme worth $5.86M as of Q2 2026.
  • SEB Asset Management bought 40,218 Halozyme shares in Q2 2026, an estimated $2.74M.
  • Halozyme made up 0.02% of SEB Asset Management's portfolio in Q2 2026, its #435 holding.
  • SEB Asset Management first reported a position in Halozyme in Q1 2026 and has held it in 2 quarters since.
  • 629 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on SEB Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.